Sudarshan Pharma Industries Ltd Stock Price Today (NSE: SUDARSHAN)
Fundamental Score
Sudarshan Pharma Industries Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Sudarshan Pharma Industries Ltd share price today is ₹34.20, down 9.74% on NSE/BSE as of 4 August 2026. Sudarshan Pharma Industries Ltd (SUDARSHAN) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹1.00K (Cr). The 52-week high for SUDARSHAN share price is ₹42.79 and the 52-week low is ₹18.50. At a P/E ratio of 42.99x, SUDARSHAN is currently trading above its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 16.26% and a debt-to-equity ratio of 1.84.
Sudarshan Pharma Industries Ltd Share Price Chart — NSE/BSE Historical Performance
Sudarshan Pharma Industries Ltd share price chart: -1.30% return over the past month. 52-week high ₹42.79, 52-week low ₹18.50.
Sudarshan Pharma Industries Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹38.39 | ₹38.39 | ₹36.00 | ₹36.00 | 2.64L (Cr) | |
| ₹38.00 | ₹38.00 | ₹36.88 | ₹37.89 | 48.00K (Cr) | |
| ₹39.49 | ₹40.55 | ₹38.50 | ₹40.42 | 6.28L (Cr) | |
| ₹41.98 | ₹41.98 | ₹39.36 | ₹39.72 | 1.40L (Cr) | |
| ₹40.80 | ₹42.48 | ₹39.73 | ₹41.43 | 4.04L (Cr) | |
| ₹41.04 | ₹42.79 | ₹41.03 | ₹42.31 | 80.00K (Cr) | |
| ₹39.15 | ₹42.00 | ₹38.30 | ₹41.04 | 1.76L (Cr) | |
| ₹41.64 | ₹41.64 | ₹40.00 | ₹40.00 | 84.00K (Cr) | |
| ₹41.50 | ₹41.89 | ₹40.31 | ₹40.31 | 48.00K (Cr) | |
| ₹40.49 | ₹42.00 | ₹40.49 | ₹41.96 | 6.76L (Cr) |
Sudarshan Pharma Industries Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹38.39 | ₹38.39 | ₹36.00 | ₹36.00 | -6.23% | |
| ₹37.21 | ₹42.79 | ₹36.00 | ₹37.89 | +1.83% | |
| ₹35.05 | ₹40.41 | ₹32.69 | ₹37.51 | +7.02% | |
| ₹31.40 | ₹36.95 | ₹27.75 | ₹35.05 | +11.62% | |
| ₹24.90 | ₹32.48 | ₹24.75 | ₹30.26 | +21.53% | |
| ₹27.04 | ₹27.79 | ₹21.94 | ₹24.24 | -10.36% | |
| ₹20.00 | ₹28.40 | ₹19.36 | ₹28.06 | +40.30% | |
| ₹27.42 | ₹28.39 | ₹18.50 | ₹19.70 | -28.15% | |
| ₹25.08 | ₹30.00 | ₹21.62 | ₹27.55 | +9.85% | |
| ₹27.10 | ₹29.00 | ₹22.80 | ₹25.13 | -7.27% | |
| ₹25.50 | ₹30.06 | ₹22.33 | ₹27.03 | +6.00% | |
| ₹33.25 | ₹33.40 | ₹25.48 | ₹26.00 | -21.80% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Sudarshan Pharma Industries Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sudarshan Pharma Industries Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SUDARSHAN across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (16.26%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (15.13%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Robust Profit Growth (24.91%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (36.72%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (29.46% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (28.20% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (54.23% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (57.39%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Premium Valuation Risk (P/E: 42.99x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Elevated Debt Levels (D/E: 1.84)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (2.19x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-66.54 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Sudarshan Pharma Industries Ltd vs Specialty Chemicals Peers
Peer Comparison - Specialty Chemicals
Compare Sudarshan Pharma Industries Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Sudarshan Pharma Industries LtdSudarshan Pharm...Selected✓ SUDARSHAN • 543828 | 59.3/100 | ₹34.20₹34 | ₹1001.62₹1001.62 | 42.99Average 43.0 Average | 16.26%Good 16.26% Good | 15.13%Good 15.13% Good | 1.84Average 1.8 Average | 54.23%Excellent 54.23% Excellent | 29.46%Excellent 29.46% Excellent | 0.00% |
Pidilite Industries LimitedPidilite Indust... PIDILITIND • 500331 | 65.3/100 | ₹1611.40₹1611 | ₹159989.82₹159989.82 | 64.97Average 65.0 Average | 23.92%Excellent 23.92% Excellent | 31.02%Excellent 31.02% Excellent | 0.04Excellent 0.0 Excellent | 16.69%Excellent 16.69% Excellent | 14.89%Good 14.89% Good | 0.73% |
Gujarat Fluorochemicals LtdGujarat Fluoroc... FLUOROCHEM • 542812 | 42.9/100 | ₹4366.80₹4367 | ₹45440.05₹45440.05 | 77.27Average 77.3 Average | 7.78%Poor 7.78% Poor | 9.86%Poor 9.86% Poor | 0.29Excellent 0.3 Excellent | 36.34%Excellent 36.34% Excellent | 13.52%Good 13.52% Good | 0.07% |
Navin Fluorine International LtdNavin Fluorine ... NAVINFLUOR • 532504 | 62.7/100 | ₹7567.50₹7568 | ₹39027.62₹39027.62 | 58.37Average 58.4 Average | 20.26%Excellent 20.26% Excellent | 21.37%Excellent 21.37% Excellent | 0.32Excellent 0.3 Excellent | 22.16%Excellent 22.16% Excellent | 22.95%Excellent 22.95% Excellent | 0.20% |
Deepak Nitrite LtdDeepak Nitrite ... DEEPAKNTR • 506401 | 32.8/100 | ₹1662.20₹1662 | ₹23159.08₹23159.08 | 41.37Average 41.4 Average | 9.97%Poor 9.97% Poor | 11.49%Average 11.49% Average | 0.28Excellent 0.3 Excellent | -6.33%Poor -6.33% Poor | 12.59%Good 12.59% Good | 0.44% |
Aether Industries LtdAether Industri... AETHER • 543534 | 36.3/100 | ₹1539.60₹1540 | ₹19624.13₹19624.13 | 86.74Average 86.7 Average | 9.66%Poor 9.66% Poor | 11.92%Average 11.92% Average | 0.19Excellent 0.2 Excellent | — — | — — | 0.00% |
Aarti Industries LtdAarti Industrie... AARTIIND • 524208 | 38.7/100 | ₹489.10₹489 | ₹18171.13₹18171.13 | 44.10Average 44.1 Average | 7.13%Poor 7.13% Poor | 6.85%Poor 6.85% Poor | 0.83Good 0.8 Good | -4.67%Poor -4.67% Poor | 12.96%Good 12.96% Good | 0.20% |
Atul LtdAtul Ltd... ATUL • 500027 | 58.2/100 | ₹6736.50₹6737 | ₹18051.49₹18051.49 | 26.58Average 26.6 Average | 11.49%Average 11.49% Average | 14.90%Average 14.90% Average | 0.03Excellent 0.0 Excellent | 1.26%Average 1.26% Average | 10.95%Good 10.95% Good | 0.49% |
BASF India LtdBASF India Ltd... BASF • 500042 | 52.2/100 | ₹3633.80₹3634 | ₹16002.35₹16002.35 | 38.38Average 38.4 Average | 10.92%Average 10.92% Average | 14.68%Average 14.68% Average | 0.03Excellent 0.0 Excellent | 7.67%Good 7.67% Good | 9.41%Good 9.41% Good | 0.68% |
Fine Organic Industries LtdFine Organic In... FINEORG • 541557 | 62.09999999999999/100 | ₹4816.50₹4817 | ₹15713.17₹15713.17 | 38.15Average 38.1 Average | 16.61%Good 16.61% Good | 21.47%Excellent 21.47% Excellent | 0.03Excellent 0.0 Excellent | 27.91%Excellent 27.91% Excellent | 15.86%Excellent 15.86% Excellent | 0.21% |
Anupam Rasayan India LtdAnupam Rasayan ... ANURAS • 543275 | 33.3/100 | ₹1207.80₹1208 | ₹14449.70₹14449.70 | 84.94Average 84.9 Average | 5.50%Poor 5.50% Poor | 7.36%Poor 7.36% Poor | 0.56Good 0.6 Good | 19.29%Excellent 19.29% Excellent | 23.88%Excellent 23.88% Excellent | 0.06% |
Top Specialty Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Pidilite Industries Limited share price159989.82 Cr
- Gujarat Fluorochemicals Ltd share price45440.05 Cr
- Navin Fluorine International Ltd share price39027.62 Cr
- Deepak Nitrite Ltd share price23159.08 Cr
- Aether Industries Ltd share price19624.13 Cr
Sudarshan Pharma Industries Ltd PE Ratio History
Historical price-to-earnings ratio for SUDARSHAN — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.47 | ₹44.59 | 94.9x |
| FY 2023 | ₹0.55 | ₹8.13 | 14.8x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Sudarshan Pharma Industries Ltd Dividend History
Annual cash dividends paid by SUDARSHAN — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2024 | ₹0.72 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Sudarshan Pharma Industries Ltd Quarterly Performance
Latest quarterly metrics for SUDARSHAN — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
36.72%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
24.91%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
29.46%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
54.23%
Compounded annual net profit growth over 5 years
Sudarshan Pharma Industries Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SUDARSHAN — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Sudarshan Pharma Industries Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Sudarshan Pharma Industries Ltd (SUDARSHAN) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Sudarshan Pharma Industries Ltd
About SUDARSHAN (Sudarshan Pharma Industries Ltd)
Sudarshan Pharma Industries Ltd is a dynamic force within the specialty chemicals sector, crafting a diverse portfolio of high-quality chemical solutions for a multitude of industr...ies. With a strong foundation built on innovation and customer-centricity, Sudarshan specializes in the creation of advanced intermediates critical for the pharmaceutical and agrochemical sectors. Beyond these key areas, the company extends its expertise to providing bespoke chemical solutions for the coating, construction, and various other industrial applications, tailoring products to meet specific and evolving needs. Sudarshan’s commitment to research and development ensures it remains at the forefront of chemical innovation, constantly exploring new avenues to deliver enhanced performance and value to its clients. The core strength of Sudarshan Pharma Industries lies in its comprehensive manufacturing capabilities, allowing for the production of both Active Pharmaceutical Ingredients (APIs) and essential vitamins. This vertical integration provides significant advantages in terms of quality control, cost efficiency, and supply chain management. Further diversifying its offerings, Sudarshan also produces fine chemicals and solvents, serving as a reliable partner for industries requiring high-purity materials. The company's unwavering focus on adherence to stringent quality standards and regulatory compliance reinforces its position as a trusted supplier of critical chemical components. Sudarshan Pharma Industries’ expansive product range caters to a wide array of specialized applications. This includes the development and manufacturing of specialized materials for leather processing, oil field operations, and lubricant formulations. The company also provides key chemicals for the creation of high-performance paints and coatings, as well as essential additives for the paper industry. Furthermore, Sudarshan manufactures ingredients used in personal care products, alongside specialized chemicals tailored for food coloring applications. By consistently providing innovative and reliable solutions, Sudarshan Pharma Industries remains a vital partner to businesses across numerous sectors, driving growth and enabling advancement.
Company Details
Key Leadership
Corporate Events
Latest News
SUDARSHAN Share Price: Frequently Asked Questions
What is the current share price of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd (SUDARSHAN) trades at ₹34.20 on NSE and BSE. Market cap ₹1.00K (Cr). Educational data only.
What is the P/E ratio of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has a P/E of 42.99x vs industry average 31.95x.
What is the Bull Run score for Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has a Bull Run score of 59.3/100 based on 25+ financial parameters.
Does Sudarshan Pharma Industries Ltd pay dividends?
Sudarshan Pharma Industries Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has ROE of 16.26%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has debt-to-equity of 1.84.
Is Sudarshan Pharma Industries Ltd a good investment?
Bull Run gives Sudarshan Pharma Industries Ltd a score of 59.3/100. This is not investment advice — consult a SEBI-registered advisor.